0.005 (1.06%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Neutral
Earnings
Very Strong
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Pharmacorp Rx Inc.
Telephone
Address
Suite 203, 303 Wellman Lane, Saskatoon, SK S7T 0J1
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.4 - 0.58
Trade Value (12mth)
US$6,773.00
1 week
0%
1 month
15.85%
YTD
-1.04%
1 year
0%
All time high
0.88
EPS 3 yr Growth
-54.30%
EBITDA Margin
-1.40%
Operating Cashflow
$2m
Free Cash Flow Return
4.60%
ROIC
-3.40%
Interest Coverage
-3.00
Quick Ratio
4.70
Shares Outstanding (Fully Diluted)
174m
HALO Sector
Other Finance
Next Company Report Date
27-Apr-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
CAD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| CAD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.02 | -0.01 | -0.01 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.02 | -0.01 | -0.01 | | | | ||
Growth | % | | | | | 10.1 | 46.6 | 4.8 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
